APA (7th ed.) Citation

A, K., AK, S., M, C., A, G., B, S., BK, M., . . . A, S. (2026). Sustained Complete Response to Brigatinib in a Young Patient With ALK-Positive NSCLC Harboring I1171N Mutation Post-Alectinib Resistance. Case reports in oncological medicine, 2026, 7372418. https://doi.org/10.1155/crom/7372418

Chicago Style (17th ed.) Citation

A, Kapoor, Singh AK, Chaudhary M, Gupta A, Sansar B, Mishra BK, Patne S, and Suresh A. "Sustained Complete Response to Brigatinib in a Young Patient With ALK-Positive NSCLC Harboring I1171N Mutation Post-Alectinib Resistance." Case Reports in Oncological Medicine 2026 (2026): 7372418. https://doi.org/10.1155/crom/7372418.

MLA (9th ed.) Citation

A, Kapoor, et al. "Sustained Complete Response to Brigatinib in a Young Patient With ALK-Positive NSCLC Harboring I1171N Mutation Post-Alectinib Resistance." Case Reports in Oncological Medicine, vol. 2026, 2026, p. 7372418, https://doi.org/10.1155/crom/7372418.